Concepedia

A. -C. Holm

A-

Statistics

Publications

7

Citations

538

H-Index

7

Active since

1979

Affiliations

AstraZeneca (Sweden)(Current)

Karolinska Institutet

A. -C. Holm is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1979–1984

7

Publications

7

Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs

S. -O. �gren, Kjell Fuxé, L.F. Agnati et al. · Journal of Neural Transmission · 1979 · 182 citations

, , +13

The pharmacology of zimelidine: A 5‐HT selective reuptake inhibitor

Sven Ove Ögren, Svante B. Ross, Håkan Hall et al. · Acta Psychiatrica Scandinavica · 1981 · 112 citations

, , +17

Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia

S. -O. �gren, A. -C. Holm · Journal of Neural Transmission · 1980 · 74 citations

, , +14

Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementia

S. -O. �gren, A. -C. Holm, Håkan Hall et al. · Journal of Neural Transmission · 1984 · 52 citations

, , +9

Studies on the Role of Central 5-HT Neurons in Avoidance Learning: A Behavioral and Biochemical Analysis

Sven Ove Ögren, Kjell Fuxé, Trevor Archer et al. · Advances in experimental medicine and biology · 1981 · 48 citations

, , +13

1–5 of 7